Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tretinoin
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-23 of 23 for your search:
Start Over
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: MK1-192, NCT00180128
Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: APL2012, NCT01987297
Acute Promyelocytic Leukemia 2006 (APL)
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: P050604, NCT00378365
Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: CA/141/CB/563/09, NCT01041833
Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: ICC APL STUDY 01, NCT01226303
A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
Phase: Phase III
Type: Health services research, Treatment
Status: Active
Age: Under 16
Sponsor: Other
Protocol IDs: 2010001, NCT02200978
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 12 to 21
Sponsor: NCI, Other
Protocol IDs: AAML1331, NCI-2014-02266, U10CA180886, NCT02339740
Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Rek VEST 231-06, NCT00995332
Treatment of Acute Leukemia Relapse After Allotransplantation
Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 to 90
Sponsor: Other
Protocol IDs: Allo-Relapse-2011, NCT01369368
Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 60
Sponsor: Other
Protocol IDs: 00332/AMLSG14-09, NCT00867672
AIDA 2000 Guidelines
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 60
Sponsor: Other
Protocol IDs: AIDA2000, NCT01064570
Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-040, NCT01404949
Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Phase: Phase II
Type: Treatment
Status: Active
Age: 10 and over
Sponsor: Other
Protocol IDs: 2010-0981, NCI-2011-02767, NCT01409161
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Stage IV Melanoma
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 14-0948.cc, NCT02403778
Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCI 08-160, NCT00892190
Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CASE3912, NCI-2013-00600, NCT01820624
Phase 1 Study of TCP-ATRA for Adult Patients With AML and MDS
Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 20140328, NCT02273102
ATRA, Celecoxib, and Itraconazole as Maintenance
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 201311791, NCT02401295
"AIDA" Protocol (LAP 0493)
Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 74
Sponsor: Other
Protocol IDs: AIDA0493, NCT01064557
Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 16
Sponsor: Other
Protocol IDs: CCAPL2010, NCT01191541
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Phase: No phase specified
Type: Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: STU2574, NCT00756288
Start Over